Your home for biotech and planetary health insight and opinion.
Let's build rapport.
The paradox of biotech protectionism: Why walling off China biotech weakens America
A US ban on Chinese biotech and clinical trial collaborations would return global pharmaceutical leadership to European pharmas and investors, slow American patient access to new medicines, and accelerate the US dependency that protectionism claims to prevent.
*Keep me informed! I understand I’m opting into letting the RA Capital team contact me, which is totally fine cause they aren’t boring.
about
RApport is an online communications hub for members of the biotech and planetary health communities to share their ideas, problems, and solutions. Founded and run by employees of RA Capital, RApport is a place to gather insight and opinions from across these industries.
We encourage you to share your thoughts with us on Twitter @RApport_Bio.